| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6151250 | Contemporary Clinical Trials | 2013 | 6 Pages |
Abstract
Pragmatic trial design need not be deferred until a product is in widespread use. Incremental movement toward the more pragmatic design of Phase 3 trials is desirable.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Seema S. Sonnad, C. Daniel Mullins, Danielle Whicher, Jennifer C. Goldsack, Penny E. Mohr, Sean R. Tunis,